Transforming global heart health: The polypill strategy

Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. These conditions, which include atherosclerosis, heart attack, stroke, and heart failure, cause one in three deaths globally and one in five in the United States. Beyond that stark reality, those living with the conditions may contend with disability, psychological distress, financial burden, and reduced quality of life. Prevalence of CVD is on the rise, driven by growth and aging of the world population. Finding more effective ways to combat these illnesses holds the potential to transform global heart health, particularly among vulnerable populations.